Last Updated : February 24, 2015
Details
FilesGeneric Name:
Aclidinium bromide/formoterol fumarate dihydrate
Project Status:
Complete
Therapeutic Area:
Chronic obstructive pulmonary disease
Manufacturer:
AstraZeneca Canada Inc.
Call for patient/clinician input open:
Brand Name:
Duaklir Genuair
Project Line:
Reimbursement Review
Project Number:
SR0423-000
Call for patient/clinician input closed:
NOC Status at Filing:
Pre NOC
Performance Metric:
Achieved
Submission Type:
Initial
Indications:
Chronic Obstructive Pulmonary Disease (COPD)
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation:
Files
Last Updated : February 24, 2015